Use of multipotent mesenchymal stromal cells as part of bone marrow concentrate in the complex treatment of aseptic necrosis of the femoral head: a systematic review

Background. Avascular necrosis of the femoral head (ANFH) is a disabling disease that often leads to hip replacement. Due to the increasing incidence among the young population, various methods of organ-preserving treatment aimed at slowing down the progression of ANFH and preserving the functions o...

Full description

Saved in:
Bibliographic Details
Main Authors: Alina R. Zakirova, Alexander N. Torgashin, Svetlana S. Rodionova
Format: Article
Language:Russian
Published: Vreden Russian Research Institute of Traumatology and Orthopedics 2024-12-01
Series:Travmatologiâ i Ortopediâ Rossii
Subjects:
Online Access:https://journal.rniito.org/jour/article/viewFile/17489/pdf_1
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832594198079995904
author Alina R. Zakirova
Alexander N. Torgashin
Svetlana S. Rodionova
author_facet Alina R. Zakirova
Alexander N. Torgashin
Svetlana S. Rodionova
author_sort Alina R. Zakirova
collection DOAJ
description Background. Avascular necrosis of the femoral head (ANFH) is a disabling disease that often leads to hip replacement. Due to the increasing incidence among the young population, various methods of organ-preserving treatment aimed at slowing down the progression of ANFH and preserving the functions of the hip joint have been proposed. Today, there is a lot of controversy and disagreement over the procedure of introducing bone marrow-derived multipotent mesenchymal stromal cells (MMSCs) into the site of osteonecrosis. The aim of the study — a systematic analysis of the accumulated literature data on the effectiveness, safety, advantages and disadvantages of treating patients with aseptic necrosis of the femoral head by the tunneling method using bone marrow-derived MMSCs, as well as their impact on reducing the risk of disease progression and long-term treatment results. Methods. A 10-year literature search (2013-2023) was performed in the PubMed, Scopus and eLIBRARY databases. According to our inclusion criteria, the review included 8 high-quality studies that examined the use of MMSCs as part of bone marrow concentrate for the treatment of ANFH. Results. The surgical outcomes of 368 patients (548 hips) from 8 studies were analyzed. The mean follow-up period was from 24 to 360 months. In most cases, functional indicators improved. In the main group, where mesenchymal stromal cells were used, X-ray progression to the next stage occurred in 31.25% of cases and the need for endoprosthetics was 30.6%; in the comparison group, the progression occurred in 68.75% of cases and the need for endoprosthetics was 69.4 %. Conclusion. The use of multipotent mesenchymal stromal cells in the complex treatment of ANFH in the early (ARCO I, II, IIIA) stages of the disease can improve the hip joint function, slow down the progression of the disease and reduce the need for endoprosthetics.
format Article
id doaj-art-2d0cbe9cf1df41ee9bf9b79fc38940e1
institution Kabale University
issn 2311-2905
2542-0933
language Russian
publishDate 2024-12-01
publisher Vreden Russian Research Institute of Traumatology and Orthopedics
record_format Article
series Travmatologiâ i Ortopediâ Rossii
spelling doaj-art-2d0cbe9cf1df41ee9bf9b79fc38940e12025-01-20T02:43:24ZrusVreden Russian Research Institute of Traumatology and OrthopedicsTravmatologiâ i Ortopediâ Rossii2311-29052542-09332024-12-0130414615610.17816/2311-2905-174891361Use of multipotent mesenchymal stromal cells as part of bone marrow concentrate in the complex treatment of aseptic necrosis of the femoral head: a systematic reviewAlina R. Zakirova0https://orcid.org/0009-0004-8986-7272Alexander N. Torgashin1https://orcid.org/0000-0002-2789-6172Svetlana S. Rodionova2https://orcid.org/0000-0002-2726-8758National Medical Research Center of Traumatology and Orthopedics named after N.N. PriorovNational Medical Research Center of Traumatology and Orthopedics named after N.N. PriorovNational Medical Research Center of Traumatology and Orthopedics named after N.N. PriorovBackground. Avascular necrosis of the femoral head (ANFH) is a disabling disease that often leads to hip replacement. Due to the increasing incidence among the young population, various methods of organ-preserving treatment aimed at slowing down the progression of ANFH and preserving the functions of the hip joint have been proposed. Today, there is a lot of controversy and disagreement over the procedure of introducing bone marrow-derived multipotent mesenchymal stromal cells (MMSCs) into the site of osteonecrosis. The aim of the study — a systematic analysis of the accumulated literature data on the effectiveness, safety, advantages and disadvantages of treating patients with aseptic necrosis of the femoral head by the tunneling method using bone marrow-derived MMSCs, as well as their impact on reducing the risk of disease progression and long-term treatment results. Methods. A 10-year literature search (2013-2023) was performed in the PubMed, Scopus and eLIBRARY databases. According to our inclusion criteria, the review included 8 high-quality studies that examined the use of MMSCs as part of bone marrow concentrate for the treatment of ANFH. Results. The surgical outcomes of 368 patients (548 hips) from 8 studies were analyzed. The mean follow-up period was from 24 to 360 months. In most cases, functional indicators improved. In the main group, where mesenchymal stromal cells were used, X-ray progression to the next stage occurred in 31.25% of cases and the need for endoprosthetics was 30.6%; in the comparison group, the progression occurred in 68.75% of cases and the need for endoprosthetics was 69.4 %. Conclusion. The use of multipotent mesenchymal stromal cells in the complex treatment of ANFH in the early (ARCO I, II, IIIA) stages of the disease can improve the hip joint function, slow down the progression of the disease and reduce the need for endoprosthetics.https://journal.rniito.org/jour/article/viewFile/17489/pdf_1aseptic necrosis of the femoral headautologous bone marrow cellsbone marrow cells transplantationbone marrow aspirate concentratemultipotent mesenchymal stromal cellscore decompressiontunneling of the femoral head
spellingShingle Alina R. Zakirova
Alexander N. Torgashin
Svetlana S. Rodionova
Use of multipotent mesenchymal stromal cells as part of bone marrow concentrate in the complex treatment of aseptic necrosis of the femoral head: a systematic review
Travmatologiâ i Ortopediâ Rossii
aseptic necrosis of the femoral head
autologous bone marrow cells
bone marrow cells transplantation
bone marrow aspirate concentrate
multipotent mesenchymal stromal cells
core decompression
tunneling of the femoral head
title Use of multipotent mesenchymal stromal cells as part of bone marrow concentrate in the complex treatment of aseptic necrosis of the femoral head: a systematic review
title_full Use of multipotent mesenchymal stromal cells as part of bone marrow concentrate in the complex treatment of aseptic necrosis of the femoral head: a systematic review
title_fullStr Use of multipotent mesenchymal stromal cells as part of bone marrow concentrate in the complex treatment of aseptic necrosis of the femoral head: a systematic review
title_full_unstemmed Use of multipotent mesenchymal stromal cells as part of bone marrow concentrate in the complex treatment of aseptic necrosis of the femoral head: a systematic review
title_short Use of multipotent mesenchymal stromal cells as part of bone marrow concentrate in the complex treatment of aseptic necrosis of the femoral head: a systematic review
title_sort use of multipotent mesenchymal stromal cells as part of bone marrow concentrate in the complex treatment of aseptic necrosis of the femoral head a systematic review
topic aseptic necrosis of the femoral head
autologous bone marrow cells
bone marrow cells transplantation
bone marrow aspirate concentrate
multipotent mesenchymal stromal cells
core decompression
tunneling of the femoral head
url https://journal.rniito.org/jour/article/viewFile/17489/pdf_1
work_keys_str_mv AT alinarzakirova useofmultipotentmesenchymalstromalcellsaspartofbonemarrowconcentrateinthecomplextreatmentofasepticnecrosisofthefemoralheadasystematicreview
AT alexanderntorgashin useofmultipotentmesenchymalstromalcellsaspartofbonemarrowconcentrateinthecomplextreatmentofasepticnecrosisofthefemoralheadasystematicreview
AT svetlanasrodionova useofmultipotentmesenchymalstromalcellsaspartofbonemarrowconcentrateinthecomplextreatmentofasepticnecrosisofthefemoralheadasystematicreview